Cargando…
Neurofilaments in progressive multiple sclerosis: a systematic review
BACKGROUND: Neurofilament proteins have been extensively studied in relapsing–remitting multiple sclerosis, where they are promising biomarkers of disease activity and treatment response. Their role in progressive multiple sclerosis, where there is a particularly urgent need for improved biomarkers,...
Autores principales: | Williams, Thomas, Zetterberg, Henrik, Chataway, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357650/ https://www.ncbi.nlm.nih.gov/pubmed/32447549 http://dx.doi.org/10.1007/s00415-020-09917-x |
Ejemplares similares
-
Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled Trial
por: Williams, Thomas E., et al.
Publicado: (2022) -
Serum neurofilament light and MRI predictors of cognitive decline in
patients with secondary progressive multiple sclerosis: Analysis from the
MS-STAT randomised controlled trial
por: Williams, Thomas, et al.
Publicado: (2022) -
The prognostic significance of early blood neurofilament light chain concentration and magnetic resonance imaging variables in relapse‐onset multiple sclerosis
por: Williams, Thomas, et al.
Publicado: (2022) -
Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation
por: Gafson, Arie R., et al.
Publicado: (2022) -
Neurofilament light in blood – What more is needed for clinical implementation in multiple sclerosis?
por: Zetterberg, Henrik
Publicado: (2020)